MD · MBA
Physician specializing in genetic analysis and personalized preventive medicine, and author of Outsmart Your Genes.
Brandon Colby is a physician-expert in the fields of genetic analysis and Personalized Preventive Medicine. He holds an MD from the Mount Sinai School of Medicine, an MBA from Stanford University's Graduate School of Business, and a degree in Genetics from the University of Michigan.
Dr. Colby is the author of the book Outsmart Your Genes and has developed numerous technologies that improve the analysis, interpretation, and actionability of genome sequencing data. He is an Affiliate Specialist of the American College of Medical Genetics and Genomics (ACMG), an Associate of the American College of Preventive Medicine (ACPM), and a member of the National Society of Genetic Counselors (NSGC).
Articles by Brandon Colby, MD are reviewed for accuracy by Sequencing's medical and scientific team. This page is for informational purposes and does not constitute medical advice.
Optimize glucocorticoid therapy with genetic testing. Identify genetic markers, predict outcomes, and tailor dosages to minimize side effects and enhance treatment efficacy.
Unlock early diagnosis and personalized care for HSAN-VI through genetic testing. Discover how it aids family planning and advances in treatment research.
Genetic testing empowers accurate diagnosis and management of Hereditary Spastic Paraplegia 46, guiding personalized treatment and informing essential family planning.
Genetic testing offers crucial insights into Hyperekplexia 2, aiding diagnosis, personalized treatments, and family planning by identifying specific mutations like GLRB.
Explore how genetic testing aids in diagnosing Hyperekplexia 3, a rare neurological disorder, revealing mutations for personalized treatment and informed family planning.
Discover the role of genetic testing in diagnosing HAPR2, guiding treatments, facilitating family planning, and advancing research for better health outcomes.
Explore the role of genetic testing in diagnosing and managing Hypomyelinating Leukodystrophy 8, aiding personalized treatment and informed family planning.
Explore how genetic testing unveils the complex genetic factors of Hypoplastic Left Heart Syndrome 2, aiding in diagnosis, risk assessment, and personalized treatments.